Cohesion Technologies cuts workforce by 20%:
This article was originally published in Clinica
Executive Summary
Surgical sealant and adhesion prevention company Cohesion Technologies is cutting its workforce by some 20%. Most of the cuts will come from the company's research and development operations. The Palo Alto, California company plans to focus reserves on its initial technology platforms - CoStasis surgical haemostat and CoSeal surgical sealant. Cohesion aims to add resources in operations, sales and marketing in preparation for direct US sales of CoSeal in 2002.